Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.
Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, Cook HT, Fervenza FC, Gibson KL, Glassock RJ, Jayne DRW, Jha V, Liew A, Liu ZH, Mejía-Vilet JM, Nester CM, Radhakrishnan J, Rave EM, Reich HN, Ronco P, Sanders JF, Sethi S, Suzuki Y, Tang SCW, Tesar V, Vivarelli M, Wetzels JFM, Lytvyn L, Craig JC, Tunnicliffe DJ, Howell M, Tonelli MA, Cheung M, Earley A, Floege J.
Kidney Int. 2021 Oct;100(4):753-779. doi: 10.1016/j.kint.2021.05.015.
IgA Nephropathy: An Interesting Autoimmune Kidney Disease.
Rajasekaran A, Julian BA, Rizk DV.
Am J Med Sci. 2021 Feb;361(2):176-194. doi: 10.1016/j.amjms.2020.10.003. Epub 2020 Oct 8.
Primary glomerulonephritides.
Floege J, Amann K.
Lancet. 2016 May 14;387(10032):2036-48. doi: 10.1016/S0140-6736(16)00272-5. Epub 2016 Feb 25.
IgA nephropathy in adults-treatment standard.
Gleeson PJ, O'Shaughnessy MM, Barratt J.
Nephrol Dial Transplant. 2023 Oct 31;38(11):2464-2473. doi: 10.1093/ndt/gfad146.
IgA nephropathy.
Wyatt RJ, Julian BA.
N Engl J Med. 2013 Jun 20;368(25):2402-14. doi: 10.1056/NEJMra1206793.
The mucosal immune system and IgA nephropathy.
Gesualdo L, Di Leo V, Coppo R.
Semin Immunopathol. 2021 Oct;43(5):657-668. doi: 10.1007/s00281-021-00871-y. Epub 2021 Oct 12.
IgA nephropathy: A brief review.
Hassler JR.
Semin Diagn Pathol. 2020 May;37(3):143-147. doi: 10.1053/j.semdp.2020.03.001. Epub 2020 Mar 16.
Treatment of IgA Nephropathy: A Rapidly Evolving Field.
El Karoui K, Fervenza FC, De Vriese AS.
J Am Soc Nephrol. 2024 Jan 1;35(1):103-116. doi: 10.1681/ASN.0000000000000242. Epub 2023 Sep 29.
Pathology of IgA nephropathy.
Roberts IS.
Nat Rev Nephrol. 2014 Aug;10(8):445-54. doi: 10.1038/nrneph.2014.92. Epub 2014 May 27.
Assessing prognosis in IgA nephropathy.
Floege J, Wied S, Rauen T.
Kidney Int. 2022 Jul;102(1):22-24. doi: 10.1016/j.kint.2022.04.018.
